Literature DB >> 32900936

Gold-based therapy: From past to present.

Alice Balfourier1, Jelena Kolosnjaj-Tabi2, Nathalie Luciani1, Florent Carn1, Florence Gazeau3.   

Abstract

Despite an abundant literature on gold nanoparticles use for biomedicine, only a few of the gold-based nanodevices are currently tested in clinical trials, and none of them are approved by health agencies. Conversely, ionic gold has been used for decades to treat human rheumatoid arthritis and benefits from 70-y hindsight on medical use. With a view to open up new perspectives in gold nanoparticles research and medical use, we revisit here the literature on therapeutic gold salts. We first summarize the literature on gold salt pharmacokinetics, therapeutic effects, adverse reactions, and the present repurposing of these ancient drugs. Owing to these readings, we evidence the existence of a common metabolism of gold nanoparticles and gold ions and propose to use gold salts as a "shortcut" to assess the long-term effects of gold nanoparticles, such as their fate and toxicity, which remain challenging questions nowadays. Moreover, one of gold salts side effects (i.e., a blue discoloration of the skin exposed to light) leads us to propose a strategy to biosynthesize large gold nanoparticles from gold salts using light irradiation. These hypotheses, which will be further investigated in the near future, open up new avenues in the field of ionic gold and gold nanoparticles-based therapies.

Entities:  

Keywords:  drug repurposing; gold nanoparticles; nanomedicine; nanotoxicity; therapeutic gold salts

Mesh:

Substances:

Year:  2020        PMID: 32900936      PMCID: PMC7502769          DOI: 10.1073/pnas.2007285117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  97 in total

Review 1.  In vivo degeneration and the fate of inorganic nanoparticles.

Authors:  Neus Feliu; Dominic Docter; Markus Heine; Pablo Del Pino; Sumaira Ashraf; Jelena Kolosnjaj-Tabi; Paolo Macchiarini; Peter Nielsen; Damien Alloyeau; Florence Gazeau; Roland H Stauber; Wolfgang J Parak
Journal:  Chem Soc Rev       Date:  2016-05-03       Impact factor: 54.564

2.  Transport of gold in the body.

Authors:  E G McQueen; P W Dykes
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

Review 3.  Advances in metal-induced oxidative stress and human disease.

Authors:  Klaudia Jomova; Marian Valko
Journal:  Toxicology       Date:  2011-03-23       Impact factor: 4.221

4.  Gold-induced changes in the morphology and functional capabilities of human monocytes.

Authors:  K Ugai; M Ziff; P E Lipsky
Journal:  Arthritis Rheum       Date:  1979-12

5.  The aurosome.

Authors:  F N Ghadially
Journal:  J Rheumatol Suppl       Date:  1979

6.  Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition.

Authors:  Antonia Caroli; Silvia Simeoni; Rosalba Lepore; Anna Tramontano; Allegra Via
Journal:  Biochem Biophys Res Commun       Date:  2011-12-08       Impact factor: 3.575

7.  Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase.

Authors:  Maria Pia Rigobello; Alessandra Folda; Maria Cristina Baldoin; Guido Scutari; Alberto Bindoli
Journal:  Free Radic Res       Date:  2005-07

8.  Protein corona significantly reduces active targeting yield.

Authors:  Vahid Mirshafiee; Morteza Mahmoudi; Kaiyan Lou; Jianjun Cheng; Mary L Kraft
Journal:  Chem Commun (Camb)       Date:  2013-03-28       Impact factor: 6.222

9.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

10.  Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.

Authors:  S Gromer; L D Arscott; C H Williams; R H Schirmer; K Becker
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

View more
  16 in total

Review 1.  Osteoarthritis complications and the recent therapeutic approaches.

Authors:  Manal A Abdel-Aziz; Helmy M S Ahmed; Aziza A El-Nekeety; Mosaad A Abdel-Wahhab
Journal:  Inflammopharmacology       Date:  2021-11-09       Impact factor: 4.473

Review 2.  Nanotheranostics for Image-Guided Cancer Treatment.

Authors:  Isabel S Dennahy; Zheng Han; William M MacCuaig; Hunter M Chalfant; Anna Condacse; Jordan M Hagood; Juan C Claros-Sorto; Wajeeha Razaq; Jennifer Holter-Chakrabarty; Ronald Squires; Barish H Edil; Ajay Jain; Lacey R McNally
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

3.  Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses.

Authors:  Sui-Yuan Chang; Kuo-Yen Huang; Tai-Ling Chao; Han-Chieh Kao; Yu-Hao Pang; Lin Lu; Chun-Lun Chiu; Hsin-Chang Huang; Ting-Jen Rachel Cheng; Jim-Min Fang; Pan-Chyr Yang
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

4.  Subchronic oral toxicity evaluation of gold nanoparticles in male and female mice.

Authors:  Pei-Pei Sun; Ching-Shu Lai; Chung-Jung Hung; Periyathambi Dhaiveegan; Mei-Ling Tsai; Chun-Lun Chiu; Jim-Min Fang
Journal:  Heliyon       Date:  2021-03-25

5.  An On-Demand Drug Delivery System for Control of Epileptiform Seizures.

Authors:  Takashi Nakano; Shakila B Rizwan; David M A Myint; Jason Gray; Sean M Mackay; Paul Harris; Christopher G Perk; Brian I Hyland; Ruth Empson; Eng Wui Tan; Keshav M Dani; John Nj Reynolds; Jeffery R Wickens
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

6.  Synoviocytes from pigmented villonodular synovitis are less sensitive to cadmium-induced cell death than synoviocytes from rheumatoid arthritis.

Authors:  Héléna Farese; Mélissa Noack; Pierre Miossec
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

7.  A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria.

Authors:  Carlos Ratia; Virginio Cepas; Raquel Soengas; Yolanda Navarro; María Velasco-de Andrés; María José Iglesias; Francisco Lozano; Fernando López-Ortiz; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

8.  Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo.

Authors:  Katarina Kozics; Monika Sramkova; Kristina Kopecka; Patricia Begerova; Alena Manova; Zora Krivosikova; Zuzana Sevcikova; Aurelia Liskova; Eva Rollerova; Tibor Dubaj; Victor Puntes; Ladislava Wsolova; Peter Simon; Jana Tulinska; Alena Gabelova
Journal:  Nanomaterials (Basel)       Date:  2021-06-28       Impact factor: 5.076

9.  Nanogold Particles Suppresses 5-Flurouracil-Induced Renal Injury: An Insight into the Modulation of Nrf-2 and Its Downstream Targets, HO-1 and γ-GCS.

Authors:  Mohamed El-Sherbiny; Eslam K Fahmy; Nada H Eisa; Eman Said; Hany A Elkattawy; Hasnaa Ali Ebrahim; Nehal M Elsherbiny; Fatma M Ghoneim
Journal:  Molecules       Date:  2021-12-19       Impact factor: 4.411

Review 10.  Antimicrobial Activity Enhancers: Towards Smart Delivery of Antimicrobial Agents.

Authors:  Mariusz Skwarczynski; Sahra Bashiri; Ye Yuan; Zyta M Ziora; Osama Nabil; Keita Masuda; Mattaka Khongkow; Natchanon Rimsueb; Horacio Cabral; Uracha Ruktanonchai; Mark A T Blaskovich; Istvan Toth
Journal:  Antibiotics (Basel)       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.